open access

Vol 9, No 6 (2020)
Review paper
Published online: 2020-10-14
Get Citation

Fear of hypoglycaemia — from normality to pathology. Diagnostic criteria and therapeutic directions

Julia Krawczyk, Anna Duda-Sobczak, Dorota Zozulińska-Ziółkiewicz
DOI: 10.5603/DK.2020.0046
·
Clinical Diabetology 2020;9(6):487-492.

open access

Vol 9, No 6 (2020)
REVIEW ARTICLES
Published online: 2020-10-14

Abstract

The aim of the article is to summarize the current knowledge on the phenomenon of fear of hypoglycaemia and its impact on the metabolic control and well-being of the population of diabetic patients. The article proposes a description of clinical criteria useful for the diagnosis of the fear of hypoglycaemia in a nonnormative and harmful form. Therapeutic directions are presented that have been proven effective in the recent years in reducing the level of maladaptive fear of hypoglycaemia, while also protecting the mental health of the patients. Despite extensive knowledge and numerous clinical trials undertaken in other countries, further research on diabetes-related anxiety disorders in Polish patients is needed. It is also advisable to create a database of culturally adapted management protocols for specialists that could increase the quality and effectiveness of the assistance provided in the outpatient health care.

Abstract

The aim of the article is to summarize the current knowledge on the phenomenon of fear of hypoglycaemia and its impact on the metabolic control and well-being of the population of diabetic patients. The article proposes a description of clinical criteria useful for the diagnosis of the fear of hypoglycaemia in a nonnormative and harmful form. Therapeutic directions are presented that have been proven effective in the recent years in reducing the level of maladaptive fear of hypoglycaemia, while also protecting the mental health of the patients. Despite extensive knowledge and numerous clinical trials undertaken in other countries, further research on diabetes-related anxiety disorders in Polish patients is needed. It is also advisable to create a database of culturally adapted management protocols for specialists that could increase the quality and effectiveness of the assistance provided in the outpatient health care.
Get Citation

Keywords

diabetes, fear of hypoglycaemia, diagnostic criteria, psychotherapy

About this article
Title

Fear of hypoglycaemia — from normality to pathology. Diagnostic criteria and therapeutic directions

Journal

Clinical Diabetology

Issue

Vol 9, No 6 (2020)

Article type

Review paper

Pages

487-492

Published online

2020-10-14

DOI

10.5603/DK.2020.0046

Bibliographic record

Clinical Diabetology 2020;9(6):487-492.

Keywords

diabetes
fear of hypoglycaemia
diagnostic criteria
psychotherapy

Authors

Julia Krawczyk
Anna Duda-Sobczak
Dorota Zozulińska-Ziółkiewicz

References (54)
  1. Workgroup on Hypoglycemia, American Diabetes Association. Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia. Diabetes Care. 2005; 28(5): 1245–1249.
  2. Davis S, Alonso M. Hypoglycemia as a barrier to glycemic control. Journal of Diabetes and its Complications. 2004; 18(1): 60–68.
  3. Cryer PE. Hypoglycemia: still the limiting factor in the glycemic management of diabetes. Endocr Pract. 2008; 14(6): 750–756.
  4. Kępiński A. Lęk. 1st ed. Kraków: Wydawnictwo Literackie. ; 2002.
  5. Tatoń J, Bernas M. Hipoglikemia i neuroglikopenii u osób z cukrzycą. W: Tatoń J, Czech A. (ed). Diabetologia. Wydawnictwo Lekarskie PZWL, Warszawa 2001: 386–400.
  6. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes. 2008; 57(12): 3169–3176.
  7. Polish Diabetes Association. 2020 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clinical Diabetology. 2020; 9(1): 1–101.
  8. Szadkowska A. Ostre stany w cukrzycy. Family Medicine & Primary Care Review. 2012; 14(2): 286–290.
  9. Wierzchowiecka A, Zozulińska-Ziółkiewicz D. Hipoglikemia w cukrzycy typu 1. Diabetologia Praktyczna. 2011; 12(6): 210–215.
  10. Cryer PE. Hypoglycaemia in Diabetes: Pathophysiology, Prevalence and Prevention. 2nd ed. Alexandria: American Diabetes Association. 2013.
  11. Kalra S, Mukherjee JJ, Venkataraman S, et al. Hypoglycemia: The neglected complication. Indian J Endocrinol Metab. 2013; 17(5): 819–834.
  12. Kedia N. Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach. Diabetes Metab Syndr Obes. 2011; 4: 337–346.
  13. Davis IC, Ahmadizadeh I, Randell J, et al. Understanding the impact of hypoglycemia on the cardiovascular system. Expert Rev Endocrinol Metab. 2017; 12(1): 21–33.
  14. Henderson JN, Allen KV, Deary IJ, et al. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003; 20(12): 1016–1021.
  15. McAulay V, Deary IJ, Frier BM. Symptoms of hypoglycaemia in people with diabetes. Diabet Med. 2001; 18(9): 690–705.
  16. Gama R, Teale JD, Marks V. Best practice No 173: clinical and laboratory investigation of adult spontaneous hypoglycaemia. J Clin Pathol. 2003; 56(9): 641–646.
  17. Davis IC, Ahmadizadeh I, Randell J, et al. Understanding the impact of hypoglycemia on the cardiovascular system. Expert Rev Endocrinol Metab. 2017; 12(1): 21–33.
  18. Seaquist ER, Miller ME, Bonds DE, et al. ACCORD Investigators. The impact of frequent and unrecognized hypoglycemia on mortality in the ACCORD study. Diabetes Care. 2012; 35(2): 409–414.
  19. Yang SW, Park KH, Zhou YJ. The Impact of Hypoglycemia on the Cardiovascular System: Physiology and Pathophysiology. Angiology. 2016; 67(9): 802–809.
  20. Gogitidze Joy N, Hedrington MS, Briscoe VJ, et al. Effects of acute hypoglycemia on inflammatory and pro-atherothrombotic biomarkers in individuals with type 1 diabetes and healthy individuals. Diabetes Care. 2010; 33(7): 1529–1535.
  21. Vignesh JP, Mohan V. Hypoglycaemia unawareness. J Assoc Physicians India. 2004; 52: 727–732.
  22. Henderson JN, Allen KV, Deary IJ, et al. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med. 2003; 20(12): 1016–1021.
  23. Ahammed A, Pathan F, Afsana F, et al. The Burden of Severe Hypoglycemia on Quality of Life among Diabetes Mellitus Patients in a Tertiary Level Hospital of Bangladesh. Indian J Endocrinol Metab. 2018; 22(4): 499–504.
  24. Polonsky WH, Fisher L, Hessler D. The impact of non-severe hypoglycemia on quality of life in patients with type 2 diabetes. J Diabetes Complications. 2018; 32(4): 373–378.
  25. Pawaskar M, Iglay K, Witt EA, et al. Impact of the severity of hypoglycemia on health - Related quality of life, productivity, resource use, and costs among US patients with type 2 diabetes. J Diabetes Complications. 2018; 32(5): 451–457.
  26. Wredling RA, Theorell PG, Roll HM, et al. Psychosocial state of patients with IDDM prone to recurrent episodes of severe hypoglycemia. Diabetes Care. 1992; 15(4): 518–521.
  27. Rachman S. Anxiety. 2nd ed. Psychology Press, New York. 2004.
  28. Clément Y, Calatayud F, Belzung C. Genetic basis of anxiety-like behaviour: a critical review. Brain Res Bull. 2002; 57(1): 57–71.
  29. Óhman A. Strach i lęk z perspektywy ewolucyjnej, poznawczej i klinicznej. W: Lewis M, Haviland-Jones JM. Psychologa emocji. Gdańskie Wydawnictwo Psychologiczne, Gdańsk. 2005: 719.
  30. Cosmides L, Tooby J. Psychologia ewolucyjna a emocje. In: Lewis M, Haviland-Jones JM. Psychologia emocji. Gdańskie Wydawnictwo Psychologiczne, Gdańsk. 2005: 128.
  31. Irvine A, Cox D, Gonder-Frederick L. The Fear of Hypoglycaemia Scale. W: Bradley C. 1st ed. Handbook of Psychology and Diabetes: a guide to psychological measurement in diabetes research and practice. Psychology Press, New York. 2006.
  32. LeDoux J. Lęk. Neuronauka na tropie źródeł lęku i strachu. 1st ed. Copernicus Center Press, Kraków. 2017.
  33. Anderbro T, Gonder-Frederick L, Bolinder J, et al. Fear of hypoglycemia: relationship to hypoglycemic risk and psychological factors. Acta Diabetol. 2015; 52(3): 581–589.
  34. Shiu AT, Wong RY. Fear of hypoglycaemia among insulin-treated Hong Kong Chinese patients: implications for diabetes patient education. Patient Educ Couns. 2000; 41(3): 251–261.
  35. Cox DJ, Gonder-Frederick L, Antoun B, et al. Psychobehavioral metabolic parameters of severe hypoglycemic episodes. Diabetes Care. 1990; 13(4): 458–459.
  36. Irvine AA, Cox D, Gonder-Frederick L. Fear of hypoglycemia: relationship to physical and psychological symptoms in patients with insulin-dependent diabetes mellitus. Health Psychol. 1992; 11(2): 135–138.
  37. Polonsky WH, Davis CL, Jacobson AM, et al. Correlates of hypoglycemic fear in type I and type II diabetes mellitus. Health Psychol. 1992; 11(3): 199–202.
  38. Clarke WL, Gonder-Frederick A, Snyder AL, et al. Maternal fear of hypoglycemia in their children with insulin dependent diabetes mellitus. J Pediatr Endocrinol Metab. 1998; 11 Suppl 1: 189–194.
  39. Monaghan MC, Hilliard ME, Cogen FR, et al. Nighttime caregiving behaviors among parents of young children with type 1 diabetes: associations with illness characteristics and parent functioning. Fam Syst Health. 2009; 27(1): 28–38.
  40. Cox DJ, Irvine A, Gonder-Frederick L, et al. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care. 1987; 10(5): 617–621.
  41. Schmidt CB, Potter van Loon BJ, Kiliç E, et al. Validation of a quick screening instrument for measuring fear of hypoglycaemia in persons with diabetes. J Diabetes Complications. 2017; 31(8): 1360–1361.
  42. Anarte Ortiz MT, Caballero FF, Ruiz de Adana MS, et al. Development of a new fear of hypoglycemia scale: FH-15. Psychol Assess. 2011; 23(2): 398–405.
  43. Kamps JL, Roberts MC, Varela RE. Development of a new fear of hypoglycemia scale: preliminary results. J Pediatr Psychol. 2005; 30(3): 287–291.
  44. Böhme P, Bertin E, Cosson E, et al. GEODE group. Fear of hypoglycaemia in patients with type 1 diabetes: do patients and diabetologists feel the same way? Diabetes Metab. 2013; 39(1): 63–70.
  45. Yong YM, Shin KM, Lee KM, et al. Intensive individualized reinforcement education is important for the prevention of hypoglycemia in patients with type 2 diabetes. Diabetes Metab J. 2015; 39(2): 154–163.
  46. Bhutani G, Kalra S, Lamba S, et al. Effect of diabetic education on the knowledge, attitude and practices of diabetic patients towards prevention of hypoglycemia. Indian J Endocrinol Metab. 2015; 19(3): 383–386.
  47. Cox DJ, Kovatchev B, Koev D, et al. Hypoglycemia anticipation, awareness and treatment training (HAATT) reduces occurrence of severe hypoglycemia among adults with type 1 diabetes mellitus. Int J Behav Med. 2004; 11(4): 212–218.
  48. Hermanns N, Kulzer B, Kubiak T, et al. The effect of an education programme (HyPOS) to treat hypoglycaemia problems in patients with type 1 diabetes. Diabetes Metab Res Rev. 2007; 23(7): 528–538.
  49. Cox D, Gonder-Frederick L, Polonsky W, et al. A multicenter evaluation of blood glucose awareness training-II. Diabetes Care. 1995; 18(4): 523–528.
  50. Cox DJ, Gonder-Frederick L, Polonsky W, et al. Blood glucose awareness training (BGAT-2): long-term benefits. Diabetes Care. 2001; 24(4): 637–642.
  51. Popiel A, Pragłowska E. Psychoterapia poznawczo-behawioralna – praktyka oparta na badaniach empirycznych. Psychiatria w Praktyce Klinicznej. 2009; 2(3): 146–155.
  52. Amsberg S, Anderbro T, Wredling R, et al. A cognitive behavior therapy-based intervention among poorly controlled adult type 1 diabetes patients--a randomized controlled trial. Patient Educ Couns. 2009; 77(1): 72–80.
  53. Anderbro T. Behavior change intervention and fear of hypoglycaemia in type 1 diabetes. Karolinska Institutet, Stockholm. 2012.
  54. O'Donnell HK, Berget C, Wooldridge JS, et al. Graduated exposure to treat fear of hypoglycemia in a young adult with type 1 diabetes: A case study. Pediatr Diabetes. 2019; 20(1): 113–118.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

 

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl